We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Conjugates of Methylene Blue with Cycloalkaneindoles as New Multifunctional Agents for Potential Treatment of Neurodegenerative Disease.
- Authors
Bachurin, Sergey O.; Shevtsova, Elena F.; Makhaeva, Galina F.; Aksinenko, Alexey Yu.; Grigoriev, Vladimir V.; Goreva, Tatiana V.; Epishina, Tatiana A.; Kovaleva, Nadezhda V.; Boltneva, Natalia P.; Lushchekina, Sofya V.; Rudakova, Elena V.; Vinogradova, Darya V.; Shevtsov, Pavel N.; Pushkareva, Elena A.; Dubova, Ludmila G.; Serkova, Tatiana P.; Veselov, Ivan M.; Fisenko, Vladimir P.; Richardson, Rudy J.
- Abstract
The development of multi-target-directed ligands (MTDLs) would provide effective therapy of neurodegenerative diseases (ND) with complex and nonclear pathogenesis. A promising method to create such potential drugs is combining neuroactive pharmacophoric groups acting on different biotargets involved in the pathogenesis of ND. We developed a synthetic algorithm for the conjugation of indole derivatives and methylene blue (MB), which are pharmacophoric ligands that act on the key stages of pathogenesis. We synthesized hybrid structures and performed a comprehensive screening for a specific set of biotargets participating in the pathogenesis of ND (i.e., cholinesterases, NMDA receptor, mitochondria, and microtubules assembly). The results of the screening study enabled us to find two lead compounds (4h and 4i) which effectively inhibited cholinesterases and bound to the AChE PAS, possessed antioxidant activity, and stimulated the assembly of microtubules. One of them (4i) exhibited activity as a ligand for the ifenprodil-specific site of the NMDA receptor. In addition, this lead compound was able to bypass the inhibition of complex I and prevent calcium-induced mitochondrial depolarization, suggesting a neuroprotective property that was confirmed using a cellular calcium overload model of neurodegeneration. Thus, these new MB-cycloalkaneindole conjugates constitute a promising class of compounds for the development of multitarget neuroprotective drugs which simultaneously act on several targets, thereby providing cognitive stimulating, neuroprotective, and disease-modifying effects.
- Subjects
THERAPEUTICS; NEURODEGENERATION; INTRACELLULAR calcium; METHYL aspartate receptors; NEUROPROTECTIVE agents; CALCIUM channels; TACRINE
- Publication
International Journal of Molecular Sciences, 2022, Vol 23, Issue 22, p13925
- ISSN
1661-6596
- Publication type
Article
- DOI
10.3390/ijms232213925